A. Slingeneyer

发表

Total implantation of a remotely controlled insulin minipump in a human insulin-dependent diabetic.

J. Mirouze, P. Chaptal, M. Franetzki, 2008, Artificial organs.

Continuous Peritoneal Insulin Infusion with Portable Pumps: Factors Affecting the Operating Life of the Chronic Catheter

J Mirouze, H. Lapinski, P. Giraud, 1985, Diabetes Care.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.

B. Canaud, C. Mion, A. Slingeneyer, 1983, Nephron.

Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean?

B. Canaud, R. Aznar, C. Mion, 1988, ASAIO transactions.

Long-Term Ambulatory Peritoneal Insulin Infusion of Brittle Diabetes with Portable Pumps: Comparison with Intravenous and Subcutaneous Routes

J. Mirouze, P. Marés, J. Selam, 1983, Diabetes Care.

Experience with Long‐term Peritoneal Insulin Infusion from External Pumps

H. Lapinski, M. Rodier, J. Mirouze, 1985, Diabetic medicine : a journal of the British Diabetic Association.

One year continuous run with a totally implantable insulin infusion pump in a human diabetic.

J. Mirouze, P. Chaptal, M. Franetzki, 1983, Transactions - American Society for Artificial Internal Organs.

The Permanent Tenckhoff Catheters

A. Slingeneyer, 1989 .

Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.

G. Coles, F. Peluso, A. Slingeneyer, 1990, The New England journal of medicine.

Peritoneal Catheters and Exit-Site Practices toward Optimum Peritoneal Access: 1998 Update

B. Piraino, S. Ash, R. Gokal, 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis.

B. Canaud, G. Mourad, C. Mion, 1983, Transactions - American Society for Artificial Internal Organs.

Peritoneal Catheters and Exit -Site Practices: Toward Optimum Peritoneal Access

S. Ash, R. Gokal, D. Oreopoulos, 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis.

A. Slingeneyer, 1987, Contributions to nephrology.

Aseptic peritonitis: role of icodextrin.

A. Slingeneyer, F. Schillinger, R. Montagnac, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Factors predisposing to priapism in haemodialysis patients.

K. Koch, S. Shaldon, U. Frei, 1976, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Pathophysiology and management of hypertension in continuous ambulatory peritoneal dialysis patients.

B. Canaud, C. Mion, A. Slingeneyer, 1987, Contributions to nephrology.

The benefits and proper role of CAPD.

B. Branger, B. Canaud, G. Mourad, 1985, Contributions to nephrology.

Acquired multicystic transformation of kidneys.

E. Ritz, R. Waldherr, C. Mion, 1985, Contributions to nephrology.

Reduction in incidence of peritonitis (P) associated with continuous ambulatory peritoneal dialysis (CAPD).

C. Mion, A. Slingeneyer, C. Perez, 1979, Proceedings of the Clinical Dialysis and Transplant Forum.

Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients.

J. Bastide, C. Mion, A. Slingeneyer, 1994, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Peritonitis, a frequently lethal complication of intermittent and continuous ambulatory peritoneal dialysis.

B. Branger, C. Mion, A. Slingeneyer, 1981, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Peritonitis prevention in continuous ambulatory peritoneal dialysis: long term efficacy of a bacteriological filter.

C. Mion, A. Slingeneyer, 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

The efficiency of microbial retention by peritoneal dialysis filters.

C. Mion, A. Slingeneyer, T. Leahy, 1980, Transactions - American Society for Artificial Internal Organs.

Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.

B. Grabensee, P. Bárány, P. Grützmacher, 1993, Clinical nephrology.

Home peritoneal dialysis in diabetics with end-stage renal failure.

J. Mirouze, J. Delors, C. Mion, 1979, Contributions to nephrology.